Flu season is emerging and, although the disease is not predicted to be as prominent as years past, doctors urge people to ...

The new COVID vaccine is here, but does it bring any new side effects or reactions? Here's what the COVID booster 2024 side ...

New COVID-19 strains are emerging and with it the need for updated vaccines to protect people from the virus. So how do ...

All new Pfizer and Moderna vaccines target the Omicron variant KP.2 strain of SARS-CoV-2, the virus that causes COVID. While the Pfizer and Moderna vaccines are mRNA-based, the Novavax vaccine is ...

mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment. As ...

After a lengthy COVID-19 surge this summer, the Bay Area is about to enter the winter respiratory virus season. Explore our ...

Jefferies analyst Michael Yee maintained a Hold rating on Moderna (MRNA – Research Report) today and set a price target of $55.00. The ...

GlaxoSmithKline has filed lawsuits against Moderna in a Delaware federal court, alleging infringement of patents related to ...

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...

In addition, the company's updated COVID-19 vaccine, SPIKEVAX®, has ... firms have revised their outlooks on Moderna. Piper Sandler reduced its target for Moderna to $115 from $157, maintaining ...

The new COVID-19 vaccine rolled out across the country last month, giving people access to the most recent versions of the Moderna, Pfizer, and Novavax shots. But, given that you have options, which ...

The first batch of Moderna vaccines has reached the government’s Strategic Reserves Agency, confirmed Jakub Gołąb, ...